Contacts, documents and full notice history are available with a subscription.
Combined Synopsis/Solicitation Expired 2 notices 4 documents

6505--PET Prostate-Specific Membrane Antigen Radiopharmaceuticals Amend for Questions and Answers 36C25226Q0211

Solicitation 36C25226Q0211 Copied Notice ID 79d0e5ccd8604afc894314ea0311fa7e Copied VETERANS AFFAIRS, DEPARTMENT OF — 252-NETWORK CONTRACT OFFICE 12 (36C252)
SAM.gov
Posted
Jan 23, 2026
Deadline
Jan 26, 2026
Set-aside
None
NAICS
325412
PSC
6505

Summary

AI-generated · Jan 17, 2026

PET Prostate-Specific Membrane Antigen (PSMA) radiopharmaceuticals are being procured under a combined synopsis/solicitation. An amendment adds Attachment 1: Price Cost Schedule Template, requiring bidders to submit a price cost schedule as part of their proposal.

An Award entry exists showing Award Date blank and Award Amount of $0.00, implying no final award details are provided in this notice.

Amendment is to add the Attachment 1: Price Cost Schedule Template

From Combined Synopsis/Solicitation posted on Jan 16, 2026

PET Prostate-Specific Membrane Antigen (PSMA) Radiopharmaceuticals 36C25226Q0211 Questions & Answers Will the awarded contractor assume all responsibility and accountability for providing contingency plans, prior to the award, to include alternative sources, in advance of any event in which local radio pharmacies are unable to provide routine delivery of Prostate Specific Membrane Antigen (PSMA) diagnostic imaging products? Yes, the awarded contractor will be expected to assume full responsibility and accountability for providing contingency plans prior to the award. Typically, PSMA patients require flexibility in scheduling daily appointments. What is the specific requirement to provide PSMA for afternoon deliveries on the same day? All orders will be placed ahead of time as part of routine scheduling. In the event of a same-day order for an afternoon delivery, the order will be submitted before 10:00 AM (or another mutually agreed-upon cut-off time) to allow sufficient time for dose preparation and delivery logistics. There are currently, multiple FDA approved PSMA products available. Is this RFQ a Sole Source request? RFQ is not a Sole Source. Subject Line: "PET Prostate-Specific Membrane Antigen (PSMA) Radiopharmaceuticals"- fluciclovine F 18 (Axumin) gallium-68 PSMA-11 (Illuccix, Locametz) fluorine 18 (F 18) labeled agents piflufolastat F 18 (Pylarify) flotufolastat F 18 (Posluma)

From Combined Synopsis/Solicitation posted on Jan 23, 2026

Notice history

2
  1. Combined Synopsis/Solicitation Posted Jan 16, 2026 View
  2. Combined Synopsis/Solicitation LATEST Posted Jan 23, 2026
    • Title: 6505--PET Prostate-Specific Membrane Antigen Radiopharmaceuticals6505--PET Prostate-Specific Membrane Antigen Radiopharmaceuticals Amend for Questions and Answers
    • Description: Description was updated

Details

Solicitation number 36C25226Q0211
Notice ID 79d0e5ccd8604afc894314ea0311fa7e
Notice type Combined Synopsis/Solicitation
Product / Service (PSC) 6505
NAICS 325412
Place of performance Chicago, Illinois
Archive date Jan 31, 2026

Award Information

Awardees
0

Contacts

primary
Stacy Massey

Contracting Officer

Email

Phone

Agency

VETERANS AFFAIRS, DEPARTMENT OF
VETERANS AFFAIRS, DEPARTMENT OF
252-NETWORK CONTRACT OFFICE 12 (36C252)

Place of Performance

Department of Veterans Affairs Jesse Brown VA Medical Center
820 S. Damen Avenue
Chicago, Illinois 606412
USA

Dates

Posted Jan 23, 2026 6 months ago
Last Updated Aug 05, 2026 2 days ago
Due Jan 26, 2026 6 months ago